Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

1,400

Participants

Timeline

Start Date

June 28, 2016

Primary Completion Date

May 4, 2020

Study Completion Date

December 28, 2025

Conditions
PneumoniaDiarrheaMalariaCo-infectionDeathMalnutrition
Interventions
DRUG

Azithromycin

oral administration of Azithromycin

DRUG

Placebo

5 days of taste/appearance/bottle-matched inactive substance

Trial Locations (1)

Unknown

Kisii Teaching and Referral Hospital, Homa Bay District Hospital, St. Paul's Mission Hospital, Kisii and Homa Bay Counties

Sponsors
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Washington

OTHER